Expression of the ventral telencephalic transcription factor DLX2 was downregulated or otherwise exhibited no expression change relative to HDF in both control and FXS affected precursors throughout reprogramming (Figure 4B). The gene discussed is DLX2; the disease is fragile X syndrome.